Literature DB >> 35340665

Therapeutic Potential of Flavonoids and Zinc in COVID-19.

Harold E Landis1, Bruk Getachew2, Yousef Tizabi2.   

Abstract

The Coronavirus Disease 2019 (COVID-19) is a devastating global pandemic. Although control of inflammation and supportive care is a common practice, effective and safe disease-modifying or preventive treatments are not yet available. Recent studies demonstrate that small natural molecules belonging to polyphenol family can interfere with various stages of coronavirus entry and replication. These bioactive phytoconstituents, available as natural components in foods and medicinal plants may provide preventive and other benefits against COVID-19, particularly in older adults with micronutrient deficiencies. Another age-related nutritional deficiency may be inadequate levels of the trace metal zinc (Zn), rendering this population more susceptible to COVID-19. Here, following a brief review of 2 select flavonoids; quercetin as a potent antioxidant, and dihydromyricetin (DHM) as an effective antiviral agent together with Zn, essential for immune function, we suggest potential use of a combination of these compounds as an added prevention and/or treatment modality in COVID-19.

Entities:  

Keywords:  Covid-19; Dihydromyricetin; Flavonoids; Quercetin; Zinc

Year:  2021        PMID: 35340665      PMCID: PMC8950086     

Source DB:  PubMed          Journal:  Medpress Nutr Food Sci


  23 in total

Review 1.  Recent aspects of the effects of zinc on human health.

Authors:  Christos T Chasapis; Panagoula-Stamatina A Ntoupa; Chara A Spiliopoulou; Maria E Stefanidou
Journal:  Arch Toxicol       Date:  2020-05-12       Impact factor: 5.153

2.  Synthesis and biological evaluation of quercetin-zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells.

Authors:  Yu-Hsiang Lee; Pham-Thi Tuyet
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-05-14       Impact factor: 2.416

3.  Quercetin-Amino Acid Conjugates are Promising Anti-Cancer Agents in Drug Discovery Projects.

Authors:  Alexey V Dobrydnev; Tetiana M Tkachuk; Viktor P Atamaniuk; Maria V Popova
Journal:  Mini Rev Med Chem       Date:  2020       Impact factor: 3.862

4.  National Risk of Zinc Deficiency as Estimated by National Surveys.

Authors:  Sonja Y Hess
Journal:  Food Nutr Bull       Date:  2017-01-25       Impact factor: 2.069

5.  Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression.

Authors:  Nina Tang; Juan Ma; Ke Si Wang; Chunliu Mi; Ying Lv; Lian Xun Piao; Guang Hua Xu; Xuezheng Li; Jung Joon Lee; Xuejun Jin
Journal:  Mol Cell Biochem       Date:  2016-09-29       Impact factor: 3.396

6.  Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults.

Authors:  Yi Guo; Eunice Mah; Richard S Bruno
Journal:  Nutrition       Date:  2014-06-11       Impact factor: 4.008

7.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

Review 8.  Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment.

Authors:  Aleksandra Gąsecka; Josip A Borovac; Rui Azevedo Guerreiro; Michela Giustozzi; William Parker; Daniel Caldeira; Gemma Chiva-Blanch
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

9.  COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?

Authors:  Camillo Sargiacomo; Federica Sotgia; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2020-03-30       Impact factor: 5.682

View more
  1 in total

Review 1.  Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges.

Authors:  Ruirui Zhang; Hao Zhang; Houyin Shi; Dan Zhang; Zhuo Zhang; Hao Liu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.